
NCODA/LinkedIn
Apr 10, 2025, 12:37
NCODA Welcomes the 2025 Medically Integrated Oncology Pharmacy (MIOP) Residents
NCODA shared a post on LinkedIn:
“NCODA is excited to introduce the newest Medically Integrated Oncology Pharmacy (MIOP) Residents joining us this year:
Siân Behrendt-McLeroy, MS – Resident at Texas Oncology
Sophia Uriostigue – Resident at Tennessee Oncology
Destiney Carroll – Resident at Florida Cancer Specialists and Research Institute
These talented pharmacy professionals are embarking on an important journey in oncology pharmacy and we’re thrilled to support them as they grow and contribute to advancing patient care.
A big thank you to Florida Cancer Specialists, Texas Oncology, and Tennessee Oncology for their continued partnership in developing the future of oncology pharmacy.
Learn more about the MIOP Residency Program.”
More posts featuring NCODA on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 14, 2025, 08:25
Apr 14, 2025, 08:24
Apr 14, 2025, 08:10
Apr 14, 2025, 08:09